The newspaper quoted the sources – unnamed – as saying that the plan is still in its early stages, and the license will depend on the ongoing studies to prove that giving a fourth dose would enhance the immune defenses that waned in people following receiving the first booster dose, and reduce their risk of exposure. for severe symptoms.
The newspaper added in its report that the US Food and Drug Administration “FDA” is reviewing the data to allow a second booster dose of the “Pfizer/Biontech” and “Moderna” vaccines.
She stated that a final decision has not yet been issued in this regard, noting that it may become necessary to make the second booster dose available earlier than the fall in the event that a new mutant appears.
